Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis L Cooper

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Supportive Oncology|June 18, 2010
Hematopoietic stem cell transplantation and the 'eye of the tiger'Dennis L Cooper
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2015
A Bone to Pick Regarding Use of Magnetic Resonance Imaging to Begin Treatment in Patients With Asymptomatic Multiple MyelomaDennis L Cooper
Transplantation and Cellular Therapy|September 26, 2024
Picking the best mismatched donor in the age of posttransplant cyclophosphamideDennis L Cooper
The New England Journal of Medicine|April 30, 2015
Treatment of relapsed multiple myelomaDennis L Cooper
The New England Journal of Medicine|April 19, 2013
The bystander effect in medical careDennis L Cooper
The New England Journal of Medicine|April 19, 2002
HLA matching for hematopoietic stem-cell transplantsDennis L Cooper
Clinical Advances in Hematology & Oncology : H&O|May 14, 2021
Lenalidomide in DLBCL: are we past the cell of origin?Mendel Goldfinger, Dennis L Cooper
The New England Journal of Medicine|April 7, 2021
Sitagliptin for Prophylaxis of Acute Graft-versus-Host DiseaseDennis L Cooper, Roger Strair
Clinical Lymphoma, Myeloma & Leukemia|October 20, 2021
Refractory DLBCL: Challenges and TreatmentMendel Goldfinger, Dennis L Cooper
Nature Clinical Practice. Oncology|May 15, 2008
Does lenalidomide plus dexamethasone improve outcome in patients with relapsed multiple myeloma?Madhav V Dhodapkar, Dennis L Cooper
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Supportive Oncology|June 18, 2010
Hematopoietic stem cell transplantation and the 'eye of the tiger'Dennis L Cooper
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2015
A Bone to Pick Regarding Use of Magnetic Resonance Imaging to Begin Treatment in Patients With Asymptomatic Multiple MyelomaDennis L Cooper
Transplantation and Cellular Therapy|September 26, 2024
Picking the best mismatched donor in the age of posttransplant cyclophosphamideDennis L Cooper
The New England Journal of Medicine|April 30, 2015
Treatment of relapsed multiple myelomaDennis L Cooper
The New England Journal of Medicine|April 19, 2013
The bystander effect in medical careDennis L Cooper
The New England Journal of Medicine|April 19, 2002
HLA matching for hematopoietic stem-cell transplantsDennis L Cooper
Clinical Advances in Hematology & Oncology : H&O|May 14, 2021
Lenalidomide in DLBCL: are we past the cell of origin?Mendel Goldfinger, Dennis L Cooper
The New England Journal of Medicine|April 7, 2021
Sitagliptin for Prophylaxis of Acute Graft-versus-Host DiseaseDennis L Cooper, Roger Strair
Clinical Lymphoma, Myeloma & Leukemia|October 20, 2021
Refractory DLBCL: Challenges and TreatmentMendel Goldfinger, Dennis L Cooper
Nature Clinical Practice. Oncology|May 15, 2008
Does lenalidomide plus dexamethasone improve outcome in patients with relapsed multiple myeloma?Madhav V Dhodapkar, Dennis L Cooper
Pageof 6